By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Zealand Pharma A/S  

Smedeland 26 B

Glostrup    DK-2600  Denmark
Phone: 45-43-28-12-00 Fax: 45-43-28-12-12


SEARCH JOBS








Company News
Zealand Pharma  (ZEAL.CO) Announces Full-Year Results In Line With Guidance And Releases Its Annual Report For 2016 3/15/2017 8:21:31 AM
Zealand Pharma  (ZEAL.CO) Hosts Conference Call On March 15 At 4 PM CET To Present 2016 Full-Year Results 3/13/2017 8:29:48 AM
Zealand Pharma  (ZEAL.CO) Reports Q4 2016 Lyxumia Royalty Revenue 2/8/2017 9:38:30 AM
Notice Of The Date Of Zealand Pharma  (ZEAL.CO)'s Annual General Meeting 2017 And Of Deadline For Proposals For The Agenda 2/7/2017 10:40:28 AM
Zealand Pharma  (ZEAL.CO) Release: Patient Recruitment Completed For Phase II Trial With Glepaglutide For Treatment Of Short Bowel Syndrome 2/6/2017 9:16:59 AM
Zealand Pharma  (ZEAL.CO) Release: EU Approval Of Suliqua Triggers $10 Million Milestone Payment To Company 1/18/2017 7:10:39 AM
Zealand Pharma  (ZEAL.CO) Reports That Sanofi (SNY) Announces Soliqua 100/33 Now Available In The U.S. 1/4/2017 8:36:51 AM
Zealand Pharma  (ZEAL.CO) Initiates Phase IIa Clinical Trial With Dasiglucagon In A Dual-Hormone Artificial Pancreas System From Beta Bionics 12/13/2016 8:09:14 AM
Zealand Pharma  (ZEAL.CO) Release: The U.S. FDA Approves Soliqua 100/33 For The Treatment Of Adults With Type 2 Diabetes 11/22/2016 7:00:58 AM
Zealand Pharma  (ZEAL.CO) Release: CHMP Issues Positive Opinion Recommending Suliqua (Iglarlixi) For Approval In The EU 11/11/2016 8:51:51 AM
12345678910...
//-->